At close: 1:46 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
7,828.4460
16,920.4460
19,454.8460
9,175.9380
3,702.6090
Operating Income
-7,828.4460
-16,920.4460
-19,454.8460
-9,175.9380
-3,702.6090
Net Non Operating Interest Income Expense
79.8690
81.8690
12.5210
-1.1850
--
Pretax Income
-7,626.0120
-16,717.0120
-19,380.1710
-9,165.1370
-3,642.3060
Net Income Common Stockholders
-7,626.0120
-16,717.0120
-19,380.1710
-9,165.1370
-3,642.3060
Diluted NI Available to Com Stockholders
-7,626.0120
-16,717.0120
-19,380.1710
-9,165.1370
-3,642.3060
Basic EPS
-0.55
-1.26
-1.66
-0.90
-0.35
Diluted EPS
-0.55
-1.26
-1.66
-0.90
-0.35
Basic Average Shares
14,097.7810
13,267.4700
11,674.8020
10,183.4860
10,460.2090
Diluted Average Shares
14,097.7810
13,267.4700
11,674.8020
10,183.4860
10,460.2090
Total Operating Income as Reported
-7,705.8810
-16,798.8810
-19,392.6920
-9,163.9520
-3,642.3060
Total Expenses
7,828.4460
16,920.4460
19,454.8460
9,175.9380
3,702.6090
Net Income from Continuing & Discontinued Operation
-7,626.0120
-16,717.0120
-19,380.1710
-9,165.1370
-3,642.3060
Normalized Income
-7,626.0120
-16,717.0120
-19,380.1710
-9,165.1370
-3,642.3060
Interest Income
81.0770
82.0770
12.5210
--
--
Interest Expense
1.2080
0.2080
--
1.1850
--
Net Interest Income
79.8690
81.8690
12.5210
-1.1850
--
EBIT
-7,624.8040
-16,716.8040
-19,380.1710
-9,163.9520
-3,642.3060
EBITDA
-7,624.8040
-16,716.8040
-19,380.1710
-9,163.9520
-3,642.3060
Net Income from Continuing Operation Net Minority Interest
-7,626.0120
-16,717.0120
-19,380.1710
-9,165.1370
-3,642.3060
Normalized EBITDA
-7,624.8040
-16,716.8040
-19,380.1710
-9,163.9520
-3,642.3060
12/31/2020 - 3/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
COMBI.ST CombiGene AB (publ)
2.5600
-2.29%
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1372
+1.03%
ELIC.ST Elicera Therapeutics AB (publ)
1.8450
-1.60%
IRLAB-A.ST IRLAB Therapeutics AB (publ)
12.90
-1.53%
FLUI.ST Fluicell AB (publ)
0.0530
-3.99%
KAN.ST Kancera AB (publ)
1.0520
-5.05%
CELC Celcuity Inc.
12.52
+0.48%